Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122236 · ClinicalTrials.gov registry record · NA
Combining tDCS and Neurorehabilitation to Treat Age-related Deficits of Mobility and Cognition: UPfront Walking Study
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03122236 is a NA study that has completed, run by University of Florida. The registered enrollment target is 20 participants.
The verdict
NCT03122236, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Loss of mobility and cognitive ability are serious conditions that threaten the independence of older adults. The objective of this study is to initiate a line of research to develop a novel therapeutic intervention to enhance both mobility and cognition via neuroplasticity of frontal/executive circuits.
Interventions
- BEHAVIORAL Neurorehabilitation of Standard Walking
- BEHAVIORAL Neurorehabilitation of Complex Walking
- DEVICE Sham Transcranial Direct Current Stimulation (Sham tDCS)
- DEVICE Active Transcranial Direct Current Stimulation (Active tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2021-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03122236
The ClinicalTrials.gov registry entry for NCT03122236 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Neurorehabilitation of Standard Walking is the first listed.
NCT03122236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03122236 about?
NCT03122236 is a clinical study titled "Combining tDCS and Neurorehabilitation to Treat Age-related Deficits of Mobility and Cognition: UPfront Walking Study". Loss of mobility and cognitive ability are serious conditions that threaten the independence of older adults. The objective of this study is to initiate a line of research to develop a novel therapeutic intervention to enhance both mobility and cognition via neuroplasticity of frontal/executive circ...
What is the current status of trial NCT03122236?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-06-01. Estimated completion is 2021-03-06.
What interventions are being tested in trial NCT03122236?
The interventions under investigation include: Neurorehabilitation of Standard Walking (BEHAVIORAL), Neurorehabilitation of Complex Walking (BEHAVIORAL), Sham Transcranial Direct Current Stimulation (Sham tDCS) (DEVICE), Active Transcranial Direct Current Stimulation (Active tDCS) (DEVICE).
Who is sponsoring clinical trial NCT03122236?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.